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ABSTRACT
Objective To assess neurodevelopmental outcome
during toddlerhood in very low birthweight (VLBW)
infants with absent or reverse end-diastolic ﬂow (AREDF)
in the umbilical artery (UA) during pregnancy.
Design Retrospective cohort study with matched
control group.
Setting Tertiary perinatal centre.
Patients and outcome measures We compared
longitudinally collected data on neonatal and
neurodevelopmental outcomes among 41 infants born in
our institution from 1997 to 2010 with birth weight
<1500 g and UA AREDF and 41 infants with prenatally
normal UA Doppler parameters matched for gestational
age, birth weight, sex and year of birth. We evaluated
neurodevelopmental outcome at a median (range)
corrected age of 23.3 (10.1–29.6) months using the
Bayley scales of infant development, 2nd edition (BSID-
II), and neurological examination.
Results The mental development index in UA AREDF
children (median (range) 84 (49–116)) was signiﬁcantly
lower than in controls (median (range) 91 (62–140)),
including after adjustment for confounders. Intergroup
differences in psychomotor development index (PDI;
BSID-II) and the rate of cerebral palsy or minor
neuromotor dysfunction were non-signiﬁcant.
Conclusions VLBW infants with UA AREDF have a
higher risk of poorer mental development during
toddlerhood than controls matched for gestational age,
birth weight, sex and year of birth. UA AREDF may be
considered a prenatal predictor of poorer mental
development in this population. Long-term follow-up
studies with larger cohorts are needed to better evaluate
the impact of this prenatal factor on later
neurodevelopment.
INTRODUCTION
Placental dysfunction comprising a reduction in
functional villi and small blood vessels may increase
placental resistance1 2 and impair uterine artery
blood ﬂow.3 A compensatory mechanism increases
blood ﬂow in the fetal middle cerebral arteries
(MCA), indicating redistribution to the brain.4
Placental dysfunction can also be detected by a
decrease in end-diastolic ﬂow (EDF) velocity in the
umbilical artery (UA). If placental resistance keeps
rising, it causes absent EDF (AEDF) or even reverse
EDF (REDF) in the UA.5 6 These abnormal
Doppler parameters are strong indicators of placen-
tal insufﬁciency or, in most cases, of intrauterine
growth restriction (IUGR).7 While IUGR is
associated with adverse perinatal and neurodeve-
lopmental outcomes,8 9 absent or reverse EDF
(AREDF) in the UA and REDF in particular carry
high perinatal and neonatal morbidity and mortal-
ity.10 11 Infants with UA AREDF during pregnancy
may experience neonatal complications such as
respiratory distress syndrome, bronchopulmonary
dysplasia, necrotising enterocolitis, anaemia and
cerebral bleeding.12 13 However, extensive descrip-
tions of perinatal and neonatal outcome after
AREDF8 9 14 15 have tended to overshadow those
of the long-term neurodevelopmental outcome of
this pregnancy complication.16–18
Our aim was to investigate the association
between UA AREDF and neurodevelopmental
outcome in very low birthweight (VLBW) infants at
corrected age (CA) of 2 years compared with a
matched group of controls with normal antenatal
Doppler parameters during pregnancy.
METHODS
Subjects
We undertook a retrospective analysis of all infants
with a prenatal Doppler diagnosis of UA AREDF,
What is already known on this topic?
▸ Pathological umbilical artery Doppler
parameters are evidence of placental
insufﬁciency and often synonymous with
intrauterine growth restriction.
▸ Absent or reverse end-diastolic ﬂow in the
umbilical arteries carries high perinatal and
neonatal morbidity and mortality.
What this study adds?
▸ Mental development is signiﬁcantly impaired in
very low birthweight toddlers with prenatally
absent or reverse end-diastolic ﬂow in the
umbilical arteries compared with gestational
age, birth weight, sex and year of birth
matched controls.
▸ Absent or reverse end-diastolic ﬂow in the
umbilical arteries seems to be an independent
prenatal predictor of adverse neurodevelopmental
outcome in very low birthweight infants.
F212 Brütsch S, et al. Arch Dis Child Fetal Neonatal Ed 2016;101:F212–F216. doi:10.1136/archdischild-2014-307820
Original article
weighing <1500 g at birth, and born between February 1997
and April 2010 at Zurich University Hospital (a tertiary referral
centre). Exclusion criteria were multiple pregnancy, congenital
malformation, chromosomal aberration and incomplete Doppler
or clinical maternal data. We individually matched this index
group by gestational age (GA; ±1 week), birth weight (±300 g),
sex and year of birth (±1 year) with a control group of single-
tons born in our institution and possessing normal antenatal
Doppler values and available 2-year outcome data. We deter-
mined GA from the known ﬁrst day of the last menstrual period
or sonographic ﬁrst-trimester crown–rump length,19 corrected
to the latter if the difference between these two parameters
exceeded 5 days. We deﬁned small for GA (SGA) as birth weight
<10th centile20 and major brain injury by cerebral ultrasound
as grade ≥3 intraventricular haemorrhage21 and/or cystic peri-
ventricular leukomalacia.22 A requirement for additional oxygen
at 360/7 weeks’ postmenstrual age deﬁned bronchopulmonary
dysplasia.23 Retinopathy of prematurity (ROP) was deﬁned
using International Committee criteria.24 Proven sepsis (positive
blood or cerebrospinal ﬂuid culture) was deﬁned as previously
described.25 We sourced the following sociodemographic vari-
ables from the clinical records: maternal age, parity, ethnicity
and socioeconomic status (SES),26 estimated using a validated
6-point scale of maternal education and paternal occupation,
ranging from 2 to 12 (the higher the score the lower the status).
We also evaluated maternal outcome, for example, preeclamp-
sia, histopathological chorioamnionitis and delivery mode.
Prenatal Doppler examination
Doppler studies were performed by sonographers trained in
maternofetal medicine. Waveforms were obtained on pulsed
wave Doppler ultrasound systems (Acuson 128XP10 and Allegra,
Siemens Medical Solutions, D-91052 Erlangen, Germany;
Voluson 730 Expert, GE Healthcare, USA) after identifying the
free-ﬂoating portion of the UA by colour ﬂow imaging. The high-
pass ﬁlter was 50 Hz. Doppler parameters included ﬂow mea-
surements in the UA, MCA and uterine arteries.
Neurodevelopmental outcome assessment
Comparison of neurodevelopmental outcome at CA of 2 years
between index and control groups was the primary endpoint.
All infants were prospectively examined as part of the routine
Swiss follow-up assessment of prematurity at the Zurich
Development Centre, Zurich University Infants’ Hospital, at CA
12–24 months, that is, the age the infant would be if it had
been born on its due date, and neurodevelopmental outcome
was determined. Assessment by experienced developmental pae-
diatricians blinded to prenatal UA ﬂow comprised Bayley scales
of infant development (2nd edition) and clinical and standar-
dised neurological examination.27 Expected means and SDs for
the mental and psychomotor development indices (MDI and
PDI) were 100±15. MDI and/or PDI <70 indicated neurodeve-
lopmental impairment. Standardised neurological examination
addressed active muscle power, muscle tone, deep tendon
reﬂexes and the cranial nerves. Cerebral palsy (CP) was deﬁned
as a permanent non-progressive movement and posture dis-
order, causing activity limitations due to non-progressive distur-
bances of the developing fetal or infant brain,28 and was graded
according to the modiﬁed gross motor function classiﬁcation
system (GMFCS).29 Minor neuromotor dysfunction was deﬁned
as a spectrum of motor disorders other than CP, including
abnormal tone and/or reﬂexes, and clumsy ﬁne and/or gross
motor performance. Vision and hearing were assessed either by
direct examination or caregiver report.
Statistics
Statistical analyses were performed using SPSS V.20.0 (SPSS,
Chicago, USA). We used Fisher’s exact test, independent t tests
and the Mann–Whitney U test to compare frequencies of nor-
mally and non-normally distributed variables between index
infants and controls. Comparison analyses of outcome measures
were adjusted for baseline characteristics that differed signiﬁ-
cantly between the two groups using multivariate regression ana-
lysis for the perinatal and demographic variables. Continuous
dependent variables were MDI and PDI; binary variables were
MDI <70, PDI <70, CP, minor neuromotor dysfunction, visual
and hearing problems and ongoing physical or occupational
therapy. We also analysed the association between continuous
MDI and PDI and known outcome predictor variables as
follows: in step 1, we included the predictors GA, sex, antenatal
corticosteroids, bronchopulmonary dysplasia, sepsis, major brain
injury, ROP >stage 2 and SES in the model equation one at a
time (univariate); in step 2, we performed multivariate regression
analysis to evaluate the independent effect of these variables
on the outcome measures based on their statistical importance in
the univariate analyses. We used the Kolmogorov–Smirnov
goodness-of-ﬁt statistic to test for normal distribution. A signiﬁ-
cance level of <0.05 was applied throughout.
The cantonal ethics committee approved the study protocol
(KEK-ZH-No. 2012 0182). Written consent was obtained from
all the women involved.
RESULTS
Of the 200 pregnancies complicated by AREDF observed during
the study period, 93 (47%) were excluded from the analysis
because of multiplicity (65 twins, 9 triplets), aneuploidy (n=6),
congenital malformation (n=4) and missing data (n=9). Of the
remaining 107 singleton pregnancies, 18 infants died in utero,
13 infants with a median (range) GA of 24 (23.0–25.1) weeks
died during the ﬁrst week of life and 14 infants were born with
birth weight >1500 g. Of the remaining 62 infants, 21 were lost
to follow-up. The index group, thus, comprised 41 infants, 22
(54%) of whom were male. Median (range) GA was 29.9 (24.9–
35.0) weeks and birth weight 910 (400–1460) g. UA AEDF was
present in 35 pregnancies and REDF in six (ﬁgure 1).
Figure 1 Index group selection and exclusion criteria.
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Differences in GA, birth weight, sex, major brain injury, sepsis
and SES between study infants and those lost to follow-up were
non-signiﬁcant (p>0.05). Differences in antenatal and neonatal
characteristics between index and control groups were also non-
signiﬁcant apart from higher rates of SGA (p=0.01) and ante-
natal corticosteroids for lung maturation (p=0.04) in AREDF
infants (table 1). Comparison of sociodemographics (table 1)
showed that mothers of AREDF infants were signiﬁcantly
younger than those in the control group (p=0.01).
Neurodevelopmental outcome
At assessment at median 23.3 months’ CA, AREDF infants and
controls were similar in median age, body weight, length and
head circumference (table 2). Median MDI was signiﬁcantly
lower in AREDF infants than in controls (p=0.005), and
remained so after adjustment for antenatal corticosteroids, SGA
and maternal age (p=0.03). Similarly, the proportion of infants
with MDI <70 was signiﬁcantly higher in the index group
(p=0.01, adjusted p=0.004). We observed no other intergroup
difference concerning the other measured outcome parameters.
Univariate regression analysis revealed signiﬁcant positive
associations between MDI and GA (p=0.02) and higher SES
(p=0.03). No signiﬁcant association was identiﬁed between PDI
and any predictor. Multivariate regression analysis revealed an
independent negative association between AREDF and MDI
(p=0.048; table 3).
The AREDF group comprised two infants with bilateral
spastic CP (GMFCS level 1: 18.3 months’ CA; level 2:
20.5 months’ CA), and the control group comprised two infants
with unilateral spastic CP, and one infant with dyskinetic CP (all
GMFCS level 1: 19.3, 23.8 and 21.8 months’ CA) (table 2).
Comparison of neurosensory outcome revealed no signiﬁcant
intergroup difference in the rate of visual or auditory problems.
Five AREDF infants (12%) with visual problems had myopia,
pendular nystagmus, cloudy peripheral cornea (n=1 each) and
convergent squint (n=2); three controls (7%) had myopia
(n=2) and convergent squint (n=1). Of the two AREDF infants
(5%) with hearing problems, one needed a cochlear implant
and the other had minor unilateral hearing loss.
At assessment, 14 AREDF infants (34%) and 12 controls
(29%) had ongoing physical therapy, and one infant per group
(2%) was having occupational therapy.
DISCUSSION
Our study compared outcome data at about 2 years between 41
VLBW toddlers with antenatal UA AREDF and 41 controls with
normal antenatal Doppler parameters matched for GA, birth
weight, sex and year of birth. The main observation was that of
all outcome parameters, the MDI in AREDF infants deviated by
>1 SD from the test norm, and was signiﬁcantly lower than in
controls. The difference remained signiﬁcant after adjusting for
confounders that differed signiﬁcantly between the groups,
namely antenatal corticosteroids, SGA and maternal age.
Together with earlier reports,8 30 this indicates that abnormal
antenatal Doppler parameters might be an independent pre-
dictor of adverse neurodevelopmental outcome in preterm
Table 1 Sociodemographic, antenatal and neonatal characteristics of AREDF infants and controls
AREDF infants Controls
p Value*Characteristics n=41 n=41
Sociodemographic
SES total, median (range) 6.0 (3.0–12.0) 5.0 (5.0–12.0) 0.30
Maternal age, median (range), years 35.0 (27.0–51.0) 40.0 (32.0–52.0) 0.01
Number of siblings, median (range) 1.5 (1.0–4.0) 1.0 (1.0–4.0) 0.55
Caucasian ethnicity†, n (%) 33 (80%) 36 (88%) 0.56
Antenatal
Preeclampsia, n (%) 10 (24) 19 (46) 0.06
Chorioamnionitis, n (%) 0 (0) 5 (12) 0.05
Caesarean section, n (%) 41 (100) 35 (85) 0.05
Reverse end-diastolic flow in UA, n (%) 6 (15) – –
Antenatal corticosteroids, n (%) 31 (76) 21 (51) 0.04
Neonatal
Gender, male, n (%) 22 (54) 21 (51) 0.10
Gestational age, median (range), weeks 30.2 (24.9–35.0) 29.7 (25–35.5) 0.16
Birth weight, median (range), g 915 (400–1460) 1005 (620–1450) 0.07
Small for gestational age 27 (66) 15 (37) 0.01
Head circumference, median (range), cm 25.4 (21.0–29.5) 26.6 (21.5–31.0) 0.31
Apgar at 5 min, median (range) 7.0 (2–10) 7.0 (3–10) 0.85
Umbilical artery pH, median (range) 7.30 (7.08–7.38) 7.32 (7.05–7.42) 0.56
CRIB score, median (range) 4 (0–11) 2 (0–11) 0.28
Respiratory distress syndrome, n (%) 34 (83) 35 (85) 1.00
Mandatory ventilation, median (range), days 1.6 (0–18) 1.7 (0–12) 0.15
Bronchopulmonary dysplasia, n (%) 4 (10) 3 (7) 1.00
Sepsis, n (%) 5 (12) 5 (12) 1.00
Major brain injury, n (%) 2 (5) 2 (5) 1.00
ROP >stage 2, n (%) 2 (5) 0 (0) 0.15
*χ2, independent t test or Mann–Whitney U test.
†Other ethnicities: Hispanic, Asian, Black.
AREDF, absent or reverse end-diastolic flow; CRIB, clinical risk index for babies;38 ROP, retinopathy of prematurity; SES, socioeconomic status;26 UA, umbilical artery.
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infants. This could be explained by impaired perfusion in
AREDF infants compromising the conditions for intrauterine
brain growth and development: despite an increase in brain per-
fusion, the circulatory impairment may be such that it induces a
decrease in brain growth, with inevitable repercussions on early
neurodevelopment. As reported in the fetal sheep,31 an increase
in placental impedance, reﬂected by abnormal UA Doppler para-
meters, is associated with abnormally low brain weight at birth
and delayed neurodevelopment. Impaired microstructural brain
maturation and metabolism is also related to neurodevelopmen-
tal outcome in very preterm infants,32 while brain volume is
reduced in infants with an abnormal UA:MCA pulsatility index
ratio.33
Other studies on pathological antenatal Doppler ﬂow used
less robust matching criteria with an increased UA resistance
index >95 percentile instead of UA AREDF (8; 33) or smaller
sample sizes with UA AREDF30 34 35 or included no control
group,33 but showed also that pathological antenatal Doppler
ﬂow is associated with unfavourable cognitive outcome, but not
with motor development in former VLBW infants at 2 years of
age.33 34 Another study that compared only 16 very preterm
infants with UA AREDF to GA-matched eutrophic controls
found higher rates of mental delay and a tendency to more
frequent motor problems at age 2 years, which was not surpris-
ing.35 Our study, however, matched 41 children to the GA and
also to the birth weight and detected a worse mental develop-
ment of children with AREDF.
The strengths of this study are ﬁvefold: good determination
of GA using early ultrasound; comparison with a control group
matched for sex, GA, birth weight and year of birth; highest
sample size of children with UA AREDF with 2-year follow-up
reported in literature; longitudinal follow-up of VLBW subjects
and standardised same-centre neurodevelopmental assessment.
The criteria used for matching the control group enabled us to
consider UA AREDF as an independent risk factor for adverse
neurodevelopmental outcome. Because of the association
between pathological UA Doppler parameters and IUGR,7
AREDF infants tended to be lighter at birth than controls.
Chorioamnionitis, which has been associated with adverse long-
term outcome in preterm infants,36 tended to be more frequent
in controls, as others have noted.35 37 A possible explanation is
that the pregnancies complicated by AREDF in our study were
likely to have been more intensively monitored than those in
the control group. The same explanation may account for the
lower exposure to antenatal corticosteroids in controls.
The main limitations of the study are its retrospective design.
Additionally, even though our study has the highest sample size
reported in the literature compared with similar studies, the
power of the analysis might have been decreased through the
high loss to follow-up. Another limitation is that the study
infants were young enough at outcome assessment for a differ-
ence in CP rate to become observable at a later stage.
Prospective outcome assessment into adolescence or early adult-
hood is deﬁnitively required in larger cohorts of infants with
abnormal UA Doppler parameters in order to better analyse the
long-term impact of AREDF on neurodevelopment and social
functioning.
In conclusion, we found that VLBW infants with UA AREDF
are at higher risk of poorer mental development at median
23.3 months’ CA than controls matched for GA, birth weight,
Table 3 Multivariate regression analyses for predictors of mental
and psychomotor development indices (Bayley scales of infant
development, 2nd edition)26 in the study subjects
Mental development index*
B SE β T p Value
AREDF −8.35 4.13 −0.25 −2.02 0.048
Gestational age 1.07 1.21 0.11 0.88 0.38
SES total −1.57 0.95 −0.20 −1.66 0.10
*F=3.50, p=0.02, R2=0.15, R2 adjusted=0.11.
AREDF, absent or reverse end-diastolic flow; SES, socioeconomic status.26
Table 2 Outcome characteristics of AREDF infants and controls at age 20 months
AREDF infants
n=41
Controls
n=41 p Value* Adjusted p value†
Age at assessment, months, median (range) 23.0 (10.1–26.0) 23.5 (15.0–29.6) 0.92 –
Weight at assessment, kg, median (range) 10.6 (9.4–11.6) 10.9 (9.1–14.7) 0.79 –
Length at assessment, cm, median (range) 80.5 (77.5–84.4) 81.0 (76.4–93.0) 0.79 –
Head circumference at assessment, cm, median (range) 47.0 (42.7–49.0) 47.2 (46.0–51.5) 0.98 –
Neurodevelopmental outcome
MDI, median (range) 84 (49–116) 91 (62–140) 0.005 0.03
PDI, median (range) 84 (49–117) 88 (50–112) 0.18 0.25
MDI <70, n (%) 10 (24%) 2 (5%) 0.01 0.004
PDI <70, n (%) 15 (37%) 8 (19%) 0.08 0.09
Cerebral palsy, n (%) 2 (5%) 3 (7%) 1.00 0.40
GMFCS level 1, n (%) 1 3
GMFCS level 2, n (%) 1 0
Minor neuromotor dysfunction, n (%) 20 (49%) 18 (44%) 0.82 0.78
Visual problems, n (%) 5 (12%) 3 (7%) 0.71 0.46
Hearing problems, n (%) 2 (5%) 0 0.23 0.78
Physical or occupational therapy, n (%) 15 (37%) 13 (32%) 0.49 0.64
Bayley scales of infant development, 2nd edition.26 MDI and PDI <70, that is, <−2 SD from index norm 100. AREDF MDI mean (SD): 81.8 (16.3) and controls MDI mean (SD): 92.4
(16.3), AREDF PDI mean (SD): 81.3 (18.1) and controls PDI mean (SD): 86.4 (18.1). GMFCS28 level ranging from 0 (normal) to 5 (most impaired).
*Independent t test or Fisher’s exact test.
†Adjusted for antenatal corticosteroids, small for gestational age status (birth weight <10th centile), and maternal age (years).
AREDF, absent or reverse end-diastolic flow; GMFCS, gross motor function classification system; MDI, mental development index; PDI, psychomotor development index.
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sex and year of birth. Our ﬁnding suggests that UA AREDF is an
independent predictor of poorer mental development in this
population. More data and longer-term follow-up are required
to eliminate SGA bias and better evaluate the impact of UA
AREDF on later neurodevelopment.
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